Hepatocyte cell death, inflammation and oxidative stress constitute key pathogenic mechanisms underlying non-alcoholic fatty liver disease (NAFLD). We aimed to investigate the role of necroptosis in human and experimental NAFLD and its association with tumour necrosis factor α (TNF-α) and oxidative stress. Serum markers of necrosis, liver receptor-interacting protein 3 (RIP3) and phosphorylated mixed lineage kinase domain-like (MLKL) were evaluated in control individuals and patients with NAFLD. C57BL/6 wild-type (WT) or RIP3-deficient (RIP3−/−) mice were fed a high-fat choline-deficient (HFCD) or methionine and choline-deficient (MCD) diet, with subsequent histological and biochemical analysis of hepatic damage. In primary murine hepatocytes, necroptosis and oxidative stress were also assessed after necrostatin-1 (Nec-1) treatment or RIP3 silencing. We show that circulating markers of necrosis and TNF-α, as well as liver RIP3 and MLKL phosphorylation were increased in NAFLD. Likewise, RIP3 and MLKL protein levels and TNF-α expression were increased in the liver of HFCD and MCD diet-fed mice. Moreover, RIP3 and MLKL sequestration in the insoluble protein fraction of NASH (non-alcoholic steatohepatitis) mice liver lysates represented an early event during stetatohepatitis progression. Functional studies in primary murine hepatocytes established the association between TNF-α-induced RIP3 expression, activation of necroptosis and oxidative stress. Strikingly, RIP3 deficiency attenuated MCD diet-induced liver injury, steatosis, inflammation, fibrosis and oxidative stress. In conclusion, necroptosis is increased in the liver of NAFLD patients and in experimental models of NASH. Further, TNF-α triggers RIP3-dependent oxidative stress during hepatocyte necroptosis. As such, targeting necroptosis appears to arrest or at least impair NAFLD progression.
Skip Nav Destination
Article navigation
Research Article|
July 22 2015
Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis Available to Purchase
Marta B. Afonso;
Marta B. Afonso
*Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal
Search for other works by this author on:
Pedro M. Rodrigues;
Pedro M. Rodrigues
*Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal
Search for other works by this author on:
Tânia Carvalho;
Tânia Carvalho
†Histology and Comparative Pathology Laboratory, Instituto de Medicina Molecular, Av. Prof. Egas Moniz, Edificio Egas Moniz, 1649-028 Lisbon, Portugal
Search for other works by this author on:
Marta Caridade;
Marta Caridade
*Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal
Search for other works by this author on:
Paula Borralho;
Paula Borralho
‡ESTEsL, Av. D. João II, 1990-096 Lisbon, Portugal
§Instituto de Anatomia Patológica, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-035 Lisbon, Portugal
║Hospital Cuf Descobertas, R. Mário Botas, Parque das Nações, 1998-018 Lisbon, Portugal
Search for other works by this author on:
Helena Cortez-Pinto;
Helena Cortez-Pinto
¶Department of Gastroenterology, Hospital Santa Maria, Faculty of Medicine, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-035 Lisbon, Portugal
Search for other works by this author on:
Rui E. Castro;
Rui E. Castro
*Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal
Search for other works by this author on:
Cecília M.P. Rodrigues
*Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal
Correspondence: Cecília M.P. Rodrigues (email [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
November 07 2014
Revision Received:
May 22 2015
Accepted:
June 15 2015
Accepted Manuscript online:
June 15 2015
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© 2015 Authors; published by Portland Press Limited
2015
Clin Sci (Lond) (2015) 129 (8): 721–739.
Article history
Received:
November 07 2014
Revision Received:
May 22 2015
Accepted:
June 15 2015
Accepted Manuscript online:
June 15 2015
Citation
Marta B. Afonso, Pedro M. Rodrigues, Tânia Carvalho, Marta Caridade, Paula Borralho, Helena Cortez-Pinto, Rui E. Castro, Cecília M.P. Rodrigues; Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis. Clin Sci (Lond) 1 October 2015; 129 (8): 721–739. doi: https://doi.org/10.1042/CS20140732
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |